Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional

Pu Su1, Liu Hong2, Yifan Zhao3

  • 1Research Center for Translational Medicine, East Hospital, Tongji University, Shanghai, China (mainland).

Insights

Elevated serum uric acid (SUA) is linked to obesity and high cholesterol in Chinese adults. Managing SUA may help prevent cardiovascular disease complications.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Public Health

Background:

  • Hyperuricemia, characterized by elevated serum uric acid (SUA) levels, is increasingly recognized for its potential links to cardiovascular diseases (CVDs).
  • Understanding these associations within diverse populations, such as the Chinese population, is crucial for public health initiatives.

Purpose of the Study:

  • To investigate the relationship between hyperuricemia and various cardiovascular disease risk factors.
  • To analyze these associations in both male and female participants within a Chinese cohort.

Main Methods:

  • Utilized data from the Chinese Hyperuricemia and Gout Database.
  • Measured serum uric acid (SUA), anthropometric data, blood pressure, and metabolic markers (glucose, cholesterol, triglycerides).
  • Employed statistical analyses including t-tests, ANOVA, Pearson's correlation, and multivariate regression models.

Main Results:

  • Hyperuricemic men exhibited significantly higher weight, BMI, blood pressure, cholesterol, and triglycerides compared to normouricemic men.
  • Hyperuricemic women were older and showed significantly greater weight, BMI, blood pressure, glucose, and triglycerides than normouricemic women.
  • Increased SUA levels correlated with higher BMI and triglycerides in both sexes, and with higher cholesterol in men, after adjustments.

Conclusions:

  • Elevated serum uric acid concentration is strongly associated with obesity and hyperlipidemia in both men and women.
  • These findings highlight the need for increased vigilance regarding cardiovascular complications in patients with hyperuricemia.
  • Lowering SUA levels may represent a potential therapeutic target for managing cardiovascular diseases.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
674
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
857
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
770
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K